Paladin Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972K Buy
3,828
+295
+8% +$68.8K 0.57% 58
2026
Q1
$864K Sell
3,533
-477
-12% -$111K 0.59% 54
2025
Q4
$830K Sell
4,010
-1,275
-24% -$252K 0.57% 59
2025
Q3
$980K Sell
5,285
-230
-4% -$39.4K 0.71% 52
2025
Q2
$842K Buy
5,515
+326
+6% +$50.1K 0.66% 59
2025
Q1
$861K Buy
5,189
+192
+4% +$30K 0.77% 52
2024
Q4
$723K Sell
4,997
-350
-7% -$54.2K 0.62% 57
2024
Q3
$867K Buy
+5,347
New +$852K 0.76% 46

Other funds holding JNJ

Paladin Wealth's JNJ Position: Q2 2026 in Review

Paladin Wealth increased its Johnson & Johnson (JNJ) stake by 8.3% in Q2 2026, buying an estimated $68.8K and bringing the position to 3,828 shares worth $972K. The position accounts for 0.57% of the portfolio, ranked #58.

Paladin Wealth first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. The position peaked at $980K in Q3 2025. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Paladin Wealth held 3,828 shares of Johnson & Johnson worth $972K as of Q2 2026.
  • Paladin Wealth bought 295 Johnson & Johnson shares in Q2 2026, an estimated $68.8K.
  • Johnson & Johnson made up 0.57% of Paladin Wealth's portfolio in Q2 2026, its #58 holding.
  • Paladin Wealth first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • Paladin Wealth's Johnson & Johnson position peaked at $980K in Q3 2025.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.